Shanghai's five-year medical products plan calls for dedicated BCI device rules
The plan for 2026 to 2030 promises full-lifecycle oversight, pre-market guidance and a standards system for brain-computer interface medical devices.
Shanghai’s Municipal Food and Drug Safety Committee on November 9 issued its 15th Five-Year Plan (2026 to 2030) for drug safety and the pharmaceutical industry, with specific measures for brain-computer interface medical devices. It promises oversight and support across a device’s whole life, a better pre-market regulatory system for BCI companies, and a dedicated standards system for BCI devices. It also calls for new test methods and test fixtures for micro- and nano-scale neural electrodes.
Shanghai hosts several implant developers, including StairMed. The plan sets direction rather than binding rules, so the effect will depend on the guidance and standards that follow. The details come from Securities Daily’s summary of the plan.
Learn more: Brain-computer interface · StairMed